| Stage | ALLE | % of rev | NDSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $818M | 100.00% | ALLE ×1.43 |
| Gross profit | $548M | 46.75% | $454M | 55.49% | NDSN +8.7pp |
| Operating income | $285M | 24.27% | $223M | 27.28% | NDSN +3.0pp |
| Pre-tax income | $268M | 22.84% | $186M | 22.74% | ALLE +0.1pp |
| Net income | $221M | 18.84% | $153M | 18.69% | ALLE +0.1pp |
| Stage | ALLE | NDSN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $818M100.00% | ALLE ×1.43 |
| Gross profit | 46.75%$548M | 55.49%$454M | NDSN +8.7pp |
| Operating income | 24.27%$285M | 27.28%$223M | NDSN +3.0pp |
| Pre-tax income | 22.84%$268M | 22.74%$186M | ALLE +0.1pp |
| Net income |
| 18.84%$221M |
| 18.69%$153M |
| ALLE +0.1pp |
No disclosed counterparties: ALLE, NDSN.